Back to search

Peptide record

TPDB26111

Antibacterial Anticancer Antiviral Toxicity standard
3 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB26111
Antibacterial Anticancer Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia
standard
No
A 3-aa standard natural multi-activity (Antibacterial, Anticancer, Antiviral, and other sources) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
VFI
Physicochemical Analysis
C20H31N3O4
ARNDCEQGHLKMPSTWY
IFV
377.48
6.02
0
0
3
-0
-1.37
3.833
226.67
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
0
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
1
I
0
L
0
K
0
M
1
F
0
P
0
S
0
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 1 L: 0 K: 0 M: 0 F: 1 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 1
Chemical Descriptors
3
C20H31N3O4
377.48
6.02
-0
-1.37
3.833
Evidence Records 3 records
Evidence 1 Activity

Activity

50% Cell death
Toxicity
>200 µM
Cytotoxic
50% Cell death | >200 | µM | target cell: Baby Hamster Kidney cells BHK-21

Target

Baby Hamster Kidney cells BHK-21

Source & Reference

NA
DBAASP
Design of Three Residues Peptides against SARS-CoV-2 Infection. | Viruses | 2022
Evidence 2 Activity

Activity

50% Cell death
Toxicity
>200 µM
Cytotoxic
50% Cell death | >200 | µM | target cell: Vero cells

Target

Vero cells

Source & Reference

NA
DBAASP
Design of Three Residues Peptides against SARS-CoV-2 Infection. | Viruses | 2022
Evidence 3 Activity

Activity

0% Hemolysis
Toxicity
200 µM
Hemolytic Cytotoxic
0% Hemolysis | 200 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Design of Three Residues Peptides against SARS-CoV-2 Infection. | Viruses | 2022